Report - HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights … · second-line treatment of patients with metastatic colorectal cancer (mCRC). Avastin, in combination with fluoropyrimidine-irinotecan-

Please pass captcha verification before submit form